Skip to content
healthcare.dev
Get a free key

Bexsero

NDC 58160-976, NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN, injection, suspension, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-976
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125546
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-976 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN50 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN50 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN50 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN25 ug/.5mL
Package NDCNDC-11Package
58160-976-205816009762010 SYRINGE in 1 CARTON (58160-976-20) / .5 mL in 1 SYRINGE (58160-976-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58160-976 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-976 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-976. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.